Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-30 | New | $9,999,891 | $9,999,891 | Equity Only | 06b | SEC link |
| 2024-09-26 | Amended | $24,999,618 | $17,499,618 | Equity Only | 06b | SEC link |
| 2024-05-06 | New | $7,500,000 | $7,500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Dr. Randall Bateman | Director |
| Dr. Joel Braunstein | Director, Executive |
| Dr. Michael Goldblatt | Director |
| Dr. David Holtzman | Director |
| Fred Miller | Director |
| Micah Onixt | Executive |